Rothwell Figg’s Post-Grant Trial Group has extensive experience handling inter partes review (IPR), covered business method (CBM) review, and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB). In addition, all of the attorneys in the practice also have substantial experience handling interference proceedings and reexaminations, prosecuting patents before the USPTO, litigating patent proceedings in federal district courts and the CAFC, and/or managing co-pending litigations and PTAB proceedings as well as counselling clients on strategic considerations in this scenario. This breadth of experience allows us to provide strategic counselling to our clients: our interference experience helps clients in situations where there is a priority contest, and a patentee is attempting to swear behind a prior art reference; our prosecution experience is helpful to clients in analyzing prosecution histories and amending claims; and our litigation experience allows us to handle appeals of PTAB proceedings. This depth of knowledge and expansive expertise distinguishes Rothwell Figg from numerous other firms.
Also distinguishing Rothwell Figg from other firms is its substantial experience across a broad array of diverse technologies. Some of these technologies includes: biotechnology and pharmaceutical fields; plant science; medical devices; computer hardware and software; Internet-specific technologies; artificial intelligence; fintech; big data technologies; advanced electronics; semiconductor devices and manufacturing; advanced telephony equipment and circuits; a wide variety of mechanical systems and devices; and general consumer goods.
Our post-grant practice has been recognized by IAM1000 – The World’s Leading Patent Professionals as “a great comparative value and renowned expertise in post-grant procedures.” To date, we have represented or are currently representing clients in more than 85 post-grant proceedings, including having participated in the very first CBM review proceeding.